Siemens Buys Former Spin-out Infineon s Array Assets in Bid to Target Molecular Dx

As part of an effort to enter the budding array-based molecular diagnostics market, Siemens purchased the biochip technology division from its 1999 semiconductor spin-off Infineon late last month, acquiring its biochip-related patent portfolio, personnel, and laboratory for an undisclosed price. Subscribers: click headline for more

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.